BRIEF-Surgalign Holdings Inc Reports Total Revenue For Three Months Ended December 31, 2022, Was $20.6 Million As Compared To $21.8 Million

Reuters

Mar 31, 2023

March 30 (Reuters) - Surgalign Holdings Inc :

* SURGALIGN HOLDINGS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2022 RESULTS

* SURGALIGN HOLDINGS INC - TOTAL REVENUE FOR THREE MONTHS ENDED DECEMBER 31, 2022, WAS $20.6 MILLION AS COMPARED TO $21.8 MILLION

* SURGALIGN HOLDINGS INC - CONTINUES TO EXECUTE ITS CORPORATE RESTRUCTURING PROGRAM; ON TRACK TO REALIZE TARGETED CASH SAVINGS OF $30 TO $35 MILLION IN 2023

* SURGALIGN HOLDINGS INC - BELIEVES IT HAS CASH ON HAND TO FUND COMPANY INTO 2023 Q4

* SURGALIGN HOLDINGS INC - CONTINUES TO EVALUATE ALL OPTIONS TO FURTHER IMPROVE ITS LIQUIDITY POSITION

* SURGALIGN HOLDINGS INC - QTRLY NET LOSS PER SHARE APPLICABLE TO SURGALIGN HOLDINGS, INC. - DILUTED $5.77

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2323725564"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2323725564\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2323725564?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2023-03-31 04:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2323725564","market":"us","top_or_hot":-1,"title":"BRIEF-Surgalign Holdings Inc Reports Total Revenue For Three Months Ended December 31, 2022, Was $20.6 Million As Compared To $21.8 Million","media":"Reuters","content":"<html><body><p>March 30 (Reuters) - Surgalign Holdings Inc   :</p><p>   * SURGALIGN HOLDINGS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2022 RESULTS</p><p>   * SURGALIGN HOLDINGS INC - TOTAL REVENUE FOR THREE MONTHS ENDED DECEMBER 31, 2022, WAS $20.6 MILLION AS COMPARED TO $21.8 MILLION</p><p>   * SURGALIGN HOLDINGS INC - CONTINUES TO EXECUTE ITS CORPORATE RESTRUCTURING PROGRAM; ON TRACK TO REALIZE TARGETED CASH SAVINGS OF $30 TO $35 MILLION IN 2023</p><p>   * SURGALIGN HOLDINGS INC - BELIEVES IT HAS CASH ON HAND TO FUND COMPANY INTO 2023 Q4</p><p>   * SURGALIGN HOLDINGS INC - CONTINUES TO EVALUATE ALL OPTIONS TO FURTHER IMPROVE ITS LIQUIDITY POSITION</p><p>   * SURGALIGN HOLDINGS INC - QTRLY NET LOSS PER SHARE APPLICABLE TO SURGALIGN HOLDINGS, INC. - DILUTED $5.77</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Surgalign Holdings Inc Reports Total Revenue For Three Months Ended December 31, 2022, Was $20.6 Million As Compared To $21.8 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Surgalign Holdings Inc Reports Total Revenue For Three Months Ended December 31, 2022, Was $20.6 Million As Compared To $21.8 Million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2023-03-31 04:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>March 30 (Reuters) - Surgalign Holdings Inc   :</p><p>   * SURGALIGN HOLDINGS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2022 RESULTS</p><p>   * SURGALIGN HOLDINGS INC - TOTAL REVENUE FOR THREE MONTHS ENDED DECEMBER 31, 2022, WAS $20.6 MILLION AS COMPARED TO $21.8 MILLION</p><p>   * SURGALIGN HOLDINGS INC - CONTINUES TO EXECUTE ITS CORPORATE RESTRUCTURING PROGRAM; ON TRACK TO REALIZE TARGETED CASH SAVINGS OF $30 TO $35 MILLION IN 2023</p><p>   * SURGALIGN HOLDINGS INC - BELIEVES IT HAS CASH ON HAND TO FUND COMPANY INTO 2023 Q4</p><p>   * SURGALIGN HOLDINGS INC - CONTINUES TO EVALUATE ALL OPTIONS TO FURTHER IMPROVE ITS LIQUIDITY POSITION</p><p>   * SURGALIGN HOLDINGS INC - QTRLY NET LOSS PER SHARE APPLICABLE TO SURGALIGN HOLDINGS, INC. - DILUTED $5.77</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LHDX","symbol_name":"Lucira Health, Inc.","start_time":0,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2323725564","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2323725564","pubTimestamp":1680206918,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"March 30 (Reuters) - Surgalign Holdings Inc   :   * SURGALIGN HOLDINGS, INC. ANNOUNCES FOURTH QUARTE","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"LHDX":"Lucira Health, Inc.","ONTF":"ON24, Inc.","SANA":"Sana Biotechnology, Inc.","CGEM":"Cullinan Therapeutics","TSS":"Total System Services","LABP":"Landos Biopharma, Inc."},"translate_title":"简介-Surgalign Holdings Inc。报告截至2022年12月31日的三个月总收入为2060万美元，而不是2180万美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ONTF":1,"SRGA":0.9,"APR":1,"LHDX":1,"LABP":1,"TSS":1,"SANA":1,"CGEM":1},"content_text":"March 30 (Reuters) - Surgalign Holdings Inc   :   * SURGALIGN HOLDINGS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2022 RESULTS   * SURGALIGN HOLDINGS INC - TOTAL REVENUE FOR THREE MONTHS ENDED DECEMBER 31, 2022, WAS $20.6 MILLION AS COMPARED TO $21.8 MILLION   * SURGALIGN HOLDINGS INC - CONTINUES TO EXECUTE ITS CORPORATE RESTRUCTURING PROGRAM; ON TRACK TO REALIZE TARGETED CASH SAVINGS OF $30 TO $35 MILLION IN 2023   * SURGALIGN HOLDINGS INC - BELIEVES IT HAS CASH ON HAND TO FUND COMPANY INTO 2023 Q4   * SURGALIGN HOLDINGS INC - CONTINUES TO EVALUATE ALL OPTIONS TO FURTHER IMPROVE ITS LIQUIDITY POSITION   * SURGALIGN HOLDINGS INC - QTRLY NET LOSS PER SHARE APPLICABLE TO SURGALIGN HOLDINGS, INC. - DILUTED $5.77Source text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}